DPDaisy Puca

Daisy Puca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daisy Puca has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tuberculous Meningitis Alters the Proteomic Landscape of Brain-Derived Extracellular Vesicles

    by Blanca V. Rodriguez, Nerketa N. L. Damiba, Harshita Tak, Nicole Beaubien, Daisy Puca, D. Brian Foster, Samarjit Das, Elizabeth W. Tucker

    Tuberculous meningitis (TB meningitis), the deadliest form of Mycobacterium tuberculosis infection, causes devastating mortality and severe neurological disability despite standard therapy. Brain injury and microglial activation are major determinants of outcome, yet the molecular mechanisms linking infection, inflammation, and neuronal injury remain poorly understood. Extracellular vesicles (EVs), critical mediators of cell-to-cell communication, have been investigated in pulmonary TB, but their role in TB meningitis remains unexplored. We used a young New Zealand White rabbit model of TB meningitis to isolate and characterize brain-derived EVs from infected and uninfected rabbits employing nanoflow cytometry, transmission electron microscopy, proteomic profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and bioinformatic analysis of pathways, cell-type enrichment, and protein-protein interaction networks (DAVID, Enrichr, and STRING databases). EV recovery from flash-frozen brain tissue proved feasible, enabling future studies using biobanked samples. M. tuberculosis infection increased EV release in brain tissue and induced a selective proteomic shift characterized by enrichment of proteins associated with TB host defense, microglial activation, and stress-response pathways, coupled with a reduced representation of neuronal and neuroprotective EV-associated proteins. These findings suggest that infection reprograms the brain EV proteome toward inflammatory and injury-associated pathways. Collectively, this study provides the first comprehensive proteomic characterization of brain-derived EVs in TB meningitis and establishes a foundational atlas of EV-associated proteins altered during infection. These findings identify candidate proteins for future biomarker validation in accessible biofluids (e.g., plasma and CSF) and provide a framework for generating hypotheses about EV-mediated host–pathogen interactions in the CNS during TB meningitis.

  • Open Access

    Bacterial Vaginosis: A Review of Pathophysiology, Epidemiology, Complications, Diagnosis, and Treatment

    by Mark Richman, Rida Nasir, Stephen Guilherme, Daisy Puca, Demetra Menoudakos, Jeffrey Wang, Rochelle Hall, Melissa Cheta, Lisa Iyeke

    Bacterial vaginosis (BV) is the most-common cause of abnormal vaginal discharge among women of reproductive age, though many are asymptomatic. It is caused by the replacement of normal vaginal Lactobacillus with Gram-negative and anaerobic organisms. BV has assumed increasing public health importance through associations with numerous adverse outcomes in both gravid and non-gravid women. Risk factors for BV include smoking, non-White race, prior BV, current other sexually transmitted diseases (STDs), inserting items in the vagina (e.g., sex, douching), and menses. Symptomatic BV has been associated with pelvic inflammatory disease (PID), miscarriage, premature rupture of membranes, chorioamnionitis, premature labor and delivery, postpartum endometritis, and post-hysterectomy vaginal cuff cellulitis. Anaerobic Gram-negative rods common to BV have also been independently associated with endometritis or PID, even in the absence of clinical BV. BV has also been independently associated with an increased risk of acquiring STDs, including acquiring and transmitting HIV. BV is not an STD, though recent sexual intercourse and multiple sexpartners are risk factors. BV causes a malodorous, white or gray vaginal discharge and is diagnosed through Amsel’s criteria. Treatment with metronidazole or clindamycin is important for symptom relief and to prevent adverse obstetric consequences, particularly among high-risk women who have had a previous preterm delivery or have a pre-pregnancy weight <50 kg.